Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller

August 7, 2018 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma

The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
News
28246711066_52e38bc591_z

MHRA sets out Brexit implementation period plan

August 7, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
News
omeros_logo_home_resized

Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Appointment
diversity_graphic

Enough talk: Action is required to achieve parity in biotech

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women

Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Feature
armind_madan

England’s top GP resigns over imflammatory online comments

August 6, 2018 Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma

England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
News

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
News
Press release
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
News
shutterstock_212035546

Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold

August 3, 2018 Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat

Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …
News
ema_logo

EMA to cut activities as it forecasts loss of 30% of staff

August 2, 2018 Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …
News

Sanofi join AstraZeneca and MSD in stockpiling medicines, 1800 jobs at risk

August 1, 2018 Research and Development Jobs, Sanofi, brexit, manufacturing, stockpiling

French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit. The company will join AstraZeneca and MSD …
News
otsuka_web

Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3

August 1, 2018 Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia

It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …
News

Pfizer notches two EU approvals, including Herceptin biosimilar

August 1, 2018 Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
News
ianread

Pharma CEO Ian Read forcasts rebate-free drug market

August 1, 2018 Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates

The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …
News
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
Appointment

Living with Behçet’s disease

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026